Skip to main content

Table 2 Targeted malaria elimination studies in the greater Mekong Subregion Q2 2015

From: Malaria eradication and elimination: views on how to translate a vision into reality

Country Start Drugs Rounds Endpoint Number of villages
Thai Myanmar border Phase 1 Q2 2013 DHA – piperaquine + PQa 3 Parasite prevalenceb 4
Thai Myanmar border Phase 2 Q4 2014 DHA – piperaquine + PQa 3 Parasite prevalenceb 300
Vietnam Q4 2013 DHA – piperaquine + PQa 3 Parasite prevalenceb 4
Cambodia - Battambang Q2 2015 DHA - piperaquine 3 Parasite prevalenceb 4
Cambodia - Preah Vihear Q2 2015 DHA - piperaquine 3 Parasite prevalenceb 8
Laos - Savannakhet Q1 2016 DHA – piperaquine + PQa 3 Parasite prevalenceb 4
Myanmar Q1 2015 DHA – piperaquine + PQa 3 Parasite prevalenceb 8
  1. PQ piperaquine
  2. aSingle low dose primaquine (15 mg)
  3. bParasite prevalence determined by high volume ultra-sensitive qPCR
\